Towards a Point-of-Care Test of CD4 + T Lymphocyte Concentrations for Immune Status Monitoring with Magnetic Flow Cytometry.
Moritz LeuthnerMathias ReisbeckMichael HelouOliver HaydenPublished in: Micromachines (2024)
For the treatment of human immunodeficiency virus (HIV)-infected patients, the regular assessment of the immune status is indispensable. The quantification of CD4 + T lymphocytes in blood by gold standard optical flow cytometry is not point-of-care testing (POCT) compatible. This incompatibility is due to unavoidable pre-analytics, expensive and bulky optics with limited portability, and complex workflow integration. Here, we propose a non-optical, magnetic flow cytometry (MFC) workflow that offers effortless integration opportunities, including minimal user interaction, integrated sample preparation and up-concentration, and miniaturization. Furthermore, we demonstrate immunomagnetic CD4 + T lymphocyte labeling in whole blood with subsequent quantification using sheath-less MFC. Showing linearity over two log scales and being largely unimpaired by hematocrit, evidence is provided for POCT capabilities of HIV patients.
Keyphrases
- flow cytometry
- human immunodeficiency virus
- antiretroviral therapy
- hiv infected patients
- hiv infected
- hiv positive
- hepatitis c virus
- hiv aids
- end stage renal disease
- molecularly imprinted
- high resolution
- newly diagnosed
- ejection fraction
- chronic kidney disease
- nk cells
- prognostic factors
- peripheral blood
- electronic health record
- high speed
- hiv testing
- peritoneal dialysis
- big data
- men who have sex with men
- artificial intelligence
- combination therapy
- tandem mass spectrometry
- silver nanoparticles
- liquid chromatography